TY - JOUR
T1 - Cardiac troponin I is a heart-specific marker in the Xenopus embryo
T2 - Expression during abnormal heart morphogenesis
AU - Drysdale, Thomas A.
AU - Tonissen, Kathryn F.
AU - Patterson, Kbistin D.
AU - Crawford, Michael J.
AU - Krieg, Paul A.
PY - 1994/10
Y1 - 1994/10
N2 - Cardiac troponin I (troponin Ic) expression is restricted to the heart at all stages of Xenopus development. Whole-mount in situ hybridization and Northern blot analysis indicates that troponin Ic is first expressed in tailbud embryos (stage 28) about the time of the first cytological heart differentiation and about 24 hr before beating tissue is observed. We have used this marker to examine abnormal heart morphogenesis in embryos treated with retinoic acid and lithium. When retinoic acid is administered to embryos prior to heart specification, heart tissue is reduced and often completely ablated. When embryos are treated after heart specification, but before the heart primordium migrates to the ventral midline, the migration is unaffected but smaller, abnormal hearts result. Lithium treatment of cleavage stage embryos causes an increase in heart tissue. In severely dorsalized embryos, heart tissue can be found around the entire embryo with the exception of a small gap at the most dorsal point. This gap indicates that migration of the heart to the ventral midline does not occur in these embryos. Later in development, a centrally located, beating heart is observed in dorsalized embryos. The timing of its appearance suggests that it is formed by movements normally associated with heart morphogenesis rather than migration.
AB - Cardiac troponin I (troponin Ic) expression is restricted to the heart at all stages of Xenopus development. Whole-mount in situ hybridization and Northern blot analysis indicates that troponin Ic is first expressed in tailbud embryos (stage 28) about the time of the first cytological heart differentiation and about 24 hr before beating tissue is observed. We have used this marker to examine abnormal heart morphogenesis in embryos treated with retinoic acid and lithium. When retinoic acid is administered to embryos prior to heart specification, heart tissue is reduced and often completely ablated. When embryos are treated after heart specification, but before the heart primordium migrates to the ventral midline, the migration is unaffected but smaller, abnormal hearts result. Lithium treatment of cleavage stage embryos causes an increase in heart tissue. In severely dorsalized embryos, heart tissue can be found around the entire embryo with the exception of a small gap at the most dorsal point. This gap indicates that migration of the heart to the ventral midline does not occur in these embryos. Later in development, a centrally located, beating heart is observed in dorsalized embryos. The timing of its appearance suggests that it is formed by movements normally associated with heart morphogenesis rather than migration.
UR - http://www.scopus.com/inward/record.url?scp=0027996950&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027996950&partnerID=8YFLogxK
U2 - 10.1006/dbio.1994.1265
DO - 10.1006/dbio.1994.1265
M3 - Article
C2 - 7958411
AN - SCOPUS:0027996950
SN - 0012-1606
VL - 165
SP - 432
EP - 441
JO - Developmental biology
JF - Developmental biology
IS - 2
ER -